Top Markets
Coin of the day
VISEN Pharmaceuticals VISEN Pharmaceuticals

VISEN Pharmaceuticals

2561
Rang în acțiuni #16882
VISEN Pharmaceuticals operates as an investment holding company, concentrating... VISEN Pharmaceuticals operates as an investment holding company, concentrating on the development and commercialization of endocrine treatments across mainland China, Hong Kong, and Taiwan. Their flagship product, Lonapegsomatropin, offers a once-weekly, long-acting growth hormone replacement designed for pediatric growth hormone deficiency. The company is also progressing other therapies, such as TransCon CNP (navepegritide), a long-acting prodrug utilizing c-type natriuretic peptide for achondroplasia, and Palopegteriparatide, a daily parathyroid hormone replacement therapy intended for chronic hypoparathyroidism. VISEN has forged strategic collaborations with Shanghai Pharmaceutical and United Family Healthcare. The enterprise was founded in 2018 and is based in Suzhou, China.
Preț acțiune
$2.52
Capitalizare de piață
$274.65M
Schimbare (1 zi)
0.46%
Schimbare (1 an)
-56.11%
Țară
CN
Tranzacționează VISEN Pharmaceuticals (2561)

Categorie

Istoricul spliturilor pentru VISEN Pharmaceuticals (2561)
Acțiunea VISEN Pharmaceuticals (simbol: 2561) a trecut printr-un total de 0 splituri.
Cel mai recent split a avut loc pe Sep 02, 2026.
O acțiune 2561 cumpărată înainte de Sep 02, 2026 este echivalentă astăzi cu 0 acțiuni 2561.
Listă splituri acțiuni
An Split Multiplu Multiplu cumulativ
Nu sunt suficiente date pentru perioada selectată.
Splituri pentru companii similare sau competitori